Financial Impacts of Paying for Gene Therapy for Sickle Cell Disease Under Alternative Pricing and Financing Mechanisms
View abstract on PubMed
Summary
This summary is machine-generated.Alternative pricing, not financing, significantly impacts gene therapy budget. An effective monopoly price can lower costs for payers while ensuring manufacturer profits and mitigating sales risk for gene therapies like those for sickle cell disease.
Area Of Science
- Health Economics
- Pharmaceutical Policy
- Gene Therapy Markets
Background
- Gene therapies represent a significant advancement in medicine, often accompanied by high costs.
- Understanding the economic implications of pricing and financing is crucial for sustainable healthcare systems.
Purpose Of The Study
- To analyze the impact of alternative pricing and financing models on the budget of payers.
- To assess the risks and returns for manufacturers of gene therapies.
- To evaluate these mechanisms in the context of gene therapy for sickle cell disease.
Main Methods
- Application of fundamental economic principles to pricing and financing.
- Interpretation of value appropriation by manufacturers.
- Financial impact analysis for payers and manufacturers.
- Case study: gene therapy for sickle cell disease in the US.
Main Results
- An effective monopoly price can guarantee manufacturer profits and lower payer budget impact compared to value-based or monopoly prices.
- For sickle cell disease gene therapy, the 10-year budget impact could range from $8.6B-$12.8B (value-based) to $7.7B (effective monopoly).
- The effective monopoly price allows manufacturers to retain over 50% of surplus while reducing sales volume risk.
Conclusions
- Financing mechanisms do not significantly mitigate gene therapy budget impacts; price is the primary driver.
- Negotiating prices down to an effective monopoly level may be achievable through options like patent buyouts.
Related Concept Videos
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
iPSCs have been successfully used to treat age-related macular degeneration (AMD), a form of...
The Concept of Multiple Allelism
Multiple allelism describes genes that exist in three or more allelic forms. Although diploid organisms, like humans, normally possess only two alleles of each gene, there are multiple alleles of many (if not most) human genes present in a population. Blood type is one example of multiple allelism. There are three alleles for blood type (HBB gene) in humans: IA, IB, and i.
Incomplete Dominance
Sickle cell anemia, which is caused by a mutation in the gene...
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Overview
Genetic engineering is the process of modifying an organism’s DNA to introduce new, desirable traits. Many organisms, from bacteria to plants and animals, have been genetically modified for academic, medical, agricultural, and industrial purposes. While genetic engineering has definite benefits, ethical concerns surround modifying humans and our food supply.
Scientists can Deliberately Modify an Organism’s Genome
Genetic engineering is possible because the genetic...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

